601 related articles for article (PubMed ID: 32283655)
21. Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick.
Suthar SK; Sharma M
Mini Rev Med Chem; 2016; 16(15):1201-1218. PubMed ID: 27121716
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer.
Steele VE; Hawk ET; Viner JL; Lubet RA
Mutat Res; 2003; 523-524():137-44. PubMed ID: 12628511
[TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory and anti-tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model.
Hosseini F; Mahdian-Shakib A; Jadidi-Niaragh F; Enderami SE; Mohammadi H; Hemmatzadeh M; Mohammed HA; Anissian A; Kokhaei P; Mirshafiey A; Hassannia H
Biomed Pharmacother; 2018 Feb; 98():793-800. PubMed ID: 29571248
[TBL] [Abstract][Full Text] [Related]
24. The use of nimesulide and its analogues in cancer chemoprevention.
Renard JF; Julémont F; de Leval X; Pirotte B
Anticancer Agents Med Chem; 2006 May; 6(3):233-7. PubMed ID: 16712451
[TBL] [Abstract][Full Text] [Related]
25. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
26. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of cancers in gastrointestinal tract with cyclooxygenase 2 inhibitors.
Wang R; Guo L; Wang P; Yang W; Lu Y; Huang Z; Tang C
Curr Pharm Des; 2013; 19(1):115-25. PubMed ID: 22950494
[TBL] [Abstract][Full Text] [Related]
28. Celecoxib: a specific COX-2 inhibitor with anticancer properties.
Koki AT; Masferrer JL
Cancer Control; 2002; 9(2 Suppl):28-35. PubMed ID: 11965228
[TBL] [Abstract][Full Text] [Related]
29. Molecular link mechanisms between inflammation and cancer.
Vendramini-Costa DB; Carvalho JE
Curr Pharm Des; 2012; 18(26):3831-52. PubMed ID: 22632748
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase as a target for colorectal cancer chemoprevention.
Moreira L; Castells A
Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
[TBL] [Abstract][Full Text] [Related]
31. 3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer.
Rakesh KS; Jagadish S; Balaji KS; Zameer F; Swaroop TR; Mohan CD; Jayarama S; Rangappa KS
Inflammation; 2016 Feb; 39(1):269-280. PubMed ID: 26363638
[TBL] [Abstract][Full Text] [Related]
32. A concise review of inflammatory biomarkers targeted cancer therapy.
Shah A; Patel C
Folia Med (Plovdiv); 2022 Aug; 64(4):572-580. PubMed ID: 36045466
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.
Umar A; Steele VE; Menter DG; Hawk ET
Semin Oncol; 2016 Feb; 43(1):65-77. PubMed ID: 26970125
[TBL] [Abstract][Full Text] [Related]
34. Targeting Inflammation to Improve Tumor Drug Delivery.
Gkretsi V; Zacharia LC; Stylianopoulos T
Trends Cancer; 2017 Sep; 3(9):621-630. PubMed ID: 28867166
[TBL] [Abstract][Full Text] [Related]
35. Recent role of inflammation in prostate diseases: chemoprevention development opportunity.
Hamid AR; Umbas R; Mochtar CA
Acta Med Indones; 2011 Jan; 43(1):59-65. PubMed ID: 21339547
[TBL] [Abstract][Full Text] [Related]
36. Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal BB; Gehlot P
Curr Opin Pharmacol; 2009 Aug; 9(4):351-69. PubMed ID: 19665429
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
Krishnan AV; Feldman D
Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
[TBL] [Abstract][Full Text] [Related]
38. beta-Catenin-mediated signaling: a novel molecular target for chemoprevention with anti-inflammatory substances.
Kundu JK; Choi KY; Surh YJ
Biochim Biophys Acta; 2006 Jan; 1765(1):14-24. PubMed ID: 16226380
[TBL] [Abstract][Full Text] [Related]
39. Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy.
Cerella C; Sobolewski C; Dicato M; Diederich M
Biochem Pharmacol; 2010 Dec; 80(12):1801-15. PubMed ID: 20615394
[TBL] [Abstract][Full Text] [Related]
40. COX-2 in inflammation and resolution.
Rajakariar R; Yaqoob MM; Gilroy DW
Mol Interv; 2006 Aug; 6(4):199-207. PubMed ID: 16960142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
